enVVeno Medical Corporation (NVNOW) Financials

NASDAQ Currency in USD Disclaimer

$0.00

Last update: 07:00 PM EST
Day's range
$0
Day's range
$0
$5M$5M$0$0-$5M-$5M-$10M-$10M-$15M-$15M-$20M-$20M-$25M-$25MEarning201820182019201920202020202120212022202220232023202420245000%5000%0%0%-5000%-5000%-10000%-10000%-15000%-15000%-20000%-20000%-25000%-25000%Profit Margin
Profit Margin
Revenue
Earnings

NVNOW Income statement / Annual

Last year (2024), enVVeno Medical Corporation's total revenue was $0.00, and the percentage change from the previous year is not available. In 2024, enVVeno Medical Corporation's net income was -$21.82 M. See enVVeno Medical Corporation,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015
Period Ended 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00 $31.24 K $186.55 K $422.11 K $785.91 K $0.00
Cost of Revenue $0.00 $546.00 K $525.00 K $452.91 K $383.97 K $0.00 $0.00 $419.66 K $810.29 K $125.42 K
Gross Profit $0.00 -$546.00 K -$525.00 K -$452.91 K -$383.97 K $31.24 K $186.55 K $2.45 K -$24.38 K -$125.42 K
Gross Profit Ratio 0 0 0 0 0 1 1 0.01 -0.03 0
Research and Development Expenses $12.25 M $13.58 M $9.91 M $5.73 M $4.25 M $2.21 M $1.24 M $649.74 K $0.00 $0.00
General & Administrative Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $11.58 M $11.66 M $15.02 M $11.16 M $4.88 M $4.91 M $6.48 M $5.46 M $4.63 M $1.29 M
Other Expenses $0.00 $0.00 $0.00 $33.27 K -$215.91 K $0.00 $0.00 $0.00 $0.00 $0.00
Operating Expenses $23.83 M $25.24 M $24.93 M $16.89 M $9.14 M $7.12 M $7.72 M $6.11 M $4.63 M $1.29 M
Cost And Expenses $0.00 $25.24 M $24.93 M $16.89 M $9.14 M $7.12 M $7.72 M $6.53 M $5.45 M $1.29 M
Interest Income $389.00 K $180.00 K $161.00 K $19.00 K $3.74 K $49.92 K $0.00 $0.00 $0.00 $0.00
Interest Expense $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $6.86 M $209.51 K $57.89 K $88.52 K
Depreciation & Amortization $0.00 $220.00 K $525.00 K $452.91 K $383.97 K $396.67 K $133.42 K $139.21 K $151.17 K $125.42 K
EBITDA -$21.29 M -$25.02 M -$24.51 M -$16.75 M -$8.75 M -$6.96 M -$6.05 M -$5.73 M -$5.38 M -$1.16 M
EBITDA Ratio 0 0 0 0 0 -222.86 -32.42 -13.58 -6.84 0
Operating Income Ratio 0 0 0 0 0 -245.67 -42.11 -14.46 -5.93 0
Total Other Income/Expenses Net $2.01 M $1.72 M $263.00 K $364.68 K -$360.00 $49.92 K -$5.19 M -$1.69 M -$929.08 K -$88.35 K
Income Before Tax -$21.82 M -$23.52 M -$24.67 M -$16.53 M -$9.14 M -$7.63 M -$13.04 M -$7.79 M -$5.59 M -$1.38 M
Income Before Tax Ratio 0 0 0 0 0 -244.07 -69.91 -18.46 -7.11 0
Income Tax Expense $0.00 $0.00 -$365.00 K -$331.41 K -$215.55 K $863.54 K $1.67 M $209.51 K -$2.14 M $314.34 K
Net Income -$21.82 M -$23.52 M -$24.30 M -$16.20 M -$8.92 M -$7.63 M -$13.04 M -$7.79 M -$3.39 M -$1.60 M
Net Income Ratio 0 0 0 0 0 -244.07 -69.91 -18.46 -4.31 0
EPS -1.27 -1.91 -2.16 -1.87 -6.91 -12.1 -34.83 -20.1 -7.72 -3.66
EPS Diluted -1.27 -1.91 -2.16 -1.87 -6.91 -12.1 -34.83 -20.1 -7.72 -3.66
Weighted Average Shares Out $17.14 M $12.30 M $11.23 M $8.68 M $1.29 M $630.42 K $374.50 K $387.69 K $438.72 K $438.72 K
Weighted Average Shares Out Diluted $17.14 M $12.30 M $11.23 M $8.68 M $1.29 M $630.42 K $374.50 K $387.69 K $438.72 K $438.72 K
Link